Choreo LLC purchased a new stake in Patterson Companies, Inc. (NASDAQ:PDCO – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,333 shares of the company’s stock, valued at approximately $257,000.
A number of other large investors have also added to or reduced their stakes in PDCO. BNP Paribas Financial Markets increased its position in Patterson Companies by 31.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 33,257 shares of the company’s stock worth $726,000 after buying an additional 7,969 shares during the period. Equity Investment Corp grew its holdings in shares of Patterson Companies by 10.6% during the 3rd quarter. Equity Investment Corp now owns 1,739,669 shares of the company’s stock worth $37,994,000 after purchasing an additional 166,899 shares in the last quarter. Goodman Financial Corp grew its holdings in shares of Patterson Companies by 19.1% during the 3rd quarter. Goodman Financial Corp now owns 543,282 shares of the company’s stock worth $11,865,000 after purchasing an additional 86,972 shares in the last quarter. Mork Capital Management LLC grew its holdings in shares of Patterson Companies by 142.9% during the 3rd quarter. Mork Capital Management LLC now owns 84,980 shares of the company’s stock worth $1,856,000 after purchasing an additional 50,000 shares in the last quarter. Finally, Barclays PLC grew its holdings in shares of Patterson Companies by 37.2% during the 3rd quarter. Barclays PLC now owns 165,715 shares of the company’s stock worth $3,619,000 after purchasing an additional 44,906 shares in the last quarter. Institutional investors own 85.43% of the company’s stock.
Patterson Companies Trading Down 0.0 %
NASDAQ PDCO opened at $31.03 on Friday. The company has a market cap of $2.74 billion, a price-to-earnings ratio of 18.15, a P/E/G ratio of 2.70 and a beta of 0.90. Patterson Companies, Inc. has a 52 week low of $19.45 and a 52 week high of $31.79. The business has a 50 day moving average price of $30.46 and a 200-day moving average price of $24.96. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34.
Insider Activity at Patterson Companies
In related news, CEO Donald Zurbay sold 1,962 shares of Patterson Companies stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $23.08, for a total transaction of $45,282.96. Following the transaction, the chief executive officer now owns 222,736 shares of the company’s stock, valued at $5,140,746.88. The trade was a 0.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.90% of the stock is owned by insiders.
Analysts Set New Price Targets
Several research firms recently weighed in on PDCO. Mizuho began coverage on Patterson Companies in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $23.00 price objective on the stock. Piper Sandler reduced their price objective on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating on the stock in a research note on Friday, December 6th. Stifel Nicolaus reduced their price objective on Patterson Companies from $25.00 to $24.00 and set a “hold” rating on the stock in a research note on Thursday, December 5th. Leerink Partnrs lowered Patterson Companies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, StockNews.com started coverage on Patterson Companies in a research note on Saturday. They set a “hold” rating on the stock. Eleven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $26.57.
View Our Latest Research Report on PDCO
Patterson Companies Profile
Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.
Recommended Stories
- Five stocks we like better than Patterson Companies
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- 3 Healthcare Dividend Stocks to Buy
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.